您的购物车当前为空
Ticolubant 是一种具有口服活性的白三烯 B4 拮抗剂,对人类中性粒细胞 LTB4 受体具有很高的亲和力(Ki = 0.78 nM),能阻断 LTB4 诱导的 Ca2+ 迁移,IC50 为 6.6±1.5 nM,并在小鼠皮肤炎症模型中显示出局部抗炎活性。


为众多的药物研发团队赋能,
让新药发现更简单!
Ticolubant 是一种具有口服活性的白三烯 B4 拮抗剂,对人类中性粒细胞 LTB4 受体具有很高的亲和力(Ki = 0.78 nM),能阻断 LTB4 诱导的 Ca2+ 迁移,IC50 为 6.6±1.5 nM,并在小鼠皮肤炎症模型中显示出局部抗炎活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 888 | In Stock | |
| 5 mg | ¥ 2,210 | In Stock | |
| 10 mg | ¥ 3,170 | In Stock | |
| 25 mg | ¥ 4,930 | In Stock | |
| 50 mg | ¥ 6,880 | In Stock | |
| 100 mg | ¥ 9,470 | In Stock | |
| 200 mg | ¥ 12,700 | In Stock |
Ticolubant 相关产品
| 产品描述 | Ticolubant is orally active leukotriene B4 antagonist with high affinity for the human neutrophil LTB4 receptor (Ki = 0.78 nM), blocks LTB4-induced Ca2+ migration with an IC50 of 6.6 ± 1.5 nM, and shows topical anti-inflammatory activity in a mouse model of skin inflammation. |
| 靶点活性 | LTB4:0.78 nM (Ki) |
| 分子量 | 460.37 |
| 分子式 | C23H19Cl2NO3S |
| CAS No. | 154413-61-3 |
| Smiles | C(=C/C(O)=O)\C1=C(OCCC2=CC=CC=C2)C=CC(CSC3=C(Cl)C=CC=C3Cl)=N1 |
| 密度 | 1.31g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (108.61 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容